PL 37

Drug Profile

PL 37

Alternative Names: Debio 0827; PL-37

Latest Information Update: 11 Oct 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Pharmaleads
  • Class Non-opioid analgesics; Small molecules
  • Mechanism of Action Aminopeptidase inhibitors; Neprilysin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Neuropathic pain
  • Preclinical Cancer pain; Pain; Postoperative pain

Most Recent Events

  • 11 Oct 2018 Pharmacodynamics data from a preclinical trials in Pain (Acute migraine pain) presented at the 17th World Congress on Pain (WCP -2018)
  • 12 Sep 2018 Preclinical trials in Pain (Acute migraine pain) in France (IV)
  • 12 Sep 2018 Preclinical trials in Postoperative pain in France (IV) before September 2018
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top